期刊文献+

人工股骨头置换术后急性肾损伤的相关因素分析 被引量:1

原文传递
导出
摘要 目的探讨人工股骨头置换术后发生急性肾损伤的影响因素。方法回顾性分析自2011-01—2019-01完成的518例人工股骨头置换术,按照术后是否发生急性肾损伤分组,即肾损伤组与未损伤组。比较2组在性别、年龄、体重指数、是否合并高尿酸血症、是否合并贫血、是否合并糖尿病、是否合并高血压、是否合并肺部感染、术前肾功能是否异常、术前白蛋白水平、术前血红蛋白水平、术前尿素氮水平、术前肌酐值、术前eGFR、ASA分级、麻醉时间、住院时间方面的差异。结果518例人工股骨头置换术后27例出现急性肾损伤,发生率为5.21%。多因素Logistic回归分析结果显示,高龄、合并糖尿病、合并高血压、术前肾功能异常、术前肌酐值高、术前低eGFR水平、ASA分级为Ⅲ、Ⅳ级是人工股骨头置换术后出现急性肾损伤的危险因素,差异有统计学意义(P<0.05)。结论人工股骨头置换术后急性肾损伤的发生率较高,术前应加强对高龄、合并糖尿病、合并高血压、肾功能异常、肌酐值高、低eGFR水平、ASA分级为Ⅲ、Ⅳ级患者的监测,及时采取有效预防措施。
出处 《中国骨与关节损伤杂志》 2021年第6期595-597,共3页 Chinese Journal of Bone and Joint Injury
  • 相关文献

参考文献12

二级参考文献53

  • 1Leeson T G, Bulugahapitiya S. Contrast-induced nephrop- athy[ J]. AJR Am J Roentgenol, 2004, 183 (6) : 1673- 1689.
  • 2Rao Q A, Newhouse J H. Risk of nephropathy after intra- venous administration of contrast material: a critical liter- ature analysis [ J ]. Radiology, 2006,239 ( 2 ) : 392-397.
  • 3Han Y, Zhu G, Han L, et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease [ J]. J Am Coll Cardiol, 2014,63 ( 1 ) :62-70.
  • 4Kushner F G, Hand M, Smith S C Jr, et al. 2009 fo- cused updates : ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction ( upda- ting the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary in- tervention (updating the 2005 guideline and 2007 focused update) : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [ J ]. Circulation, 2009, 120 ( 22 ) : 2271-2306.
  • 5Ma Y C, Zuo L, Chen J H, et al. Modified glomerular filtration rate estimating equation for chinese patients with chronic kidney disease[J]. J Am Soc Nephrol, 2006,17 (10) :2937-2944.
  • 6American Diabetes Association. Diagnosis and classifica- tion of diabetes mellitus [ J ]. Diabetes Care, 2012,35 ( Suppl 1 ) : $64-$71.
  • 7Eckardt K U, Berns J S, and classification of CKD : fient prognosis-a position Rocco M V, et al. Definition the debate should be about pa- statement from KDOQI and KDIGO[ J]. Am J Kidney Dis, 2009,53(6) :915-920.
  • 8Schweiger M J, Chambers C E, Davidson C J, et al. Pre- vention of contrast induced nephropathy: recommenda- tions for the high risk patientundergoing cardiovascular procedures [ J ]. Catheter Cardiovasc Interv, 2007, 69 (1) :135-140.
  • 9Kunieda Y, Nakagawa K, Nishimura H, et al. HMG coa reductase inhibitor suppresses the expression of tissue fac- tor and plasminogen activator inhibitor-1 induced by an- giotensin ii in cultured rat aortic endothelial ceils [ J ]. Thromb Res, 2003,110 (4) : 227-234.
  • 10Attallah N, Yassine L, Musial J, et al. The potential role of statins in contrast nephropathy [ J ]. Clin Nephrol, 2004,62(4) :273-278.

共引文献104

同被引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部